KDM6B and Hodgkins lymphoma: Anderton and collaborators reported the EBV-mediated deregulation of KDM6B and its role in Hodgkin’s lymphoma, however no previous study has assessed the role of KDM2B in the process of EBV-mediated B cells transformation.